Bioicus LAB
Early-stage life science ventures face a painful choice: hire an expensive, qualified full-time Product Manager too early and burn cash during long R&D cycles, or wait too long with complicated hiring processes and miss a critical commercial window while your investors are waiting for results.
Most spinouts can't justify £100k+ for a role that sits partially idle during 6-12 month experiments.
But without strategic guidance, R&D can make outstanding scientific products, with the risk that there is no market for them.
"I discovered this in the life science industry. A full-time product management intensity doesn't match the early biotech's rhythmic reality. The Idle Valley is real, and it costs companies thousands in misallocated resources, when being lean and fast is most critical."
The solution to the Idle Valley is fractional Product Management — strategic guidance that matches the natural Product BioRhythm of your R&D cycles. Instead of flat investment when you need burst intensity, you get expert support precisely when critical decisions are made.
5-day sprint for post-funding biotech teams
A focused intervention that clarifies R&D priorities, validates market opportunities, and creates an execution roadmap. No long-term commitment.
For teams that decide to execute with ongoing support after the Discovery Week
Some teams realize they need strategic guidance through execution. Product BioRhythm provides fractional product leadership that matches biotech R&D cycles—high intensity during decision points, light touch during development valleys.
Limited spots for initial cohort. We'll review and contact qualified applicants within 48 hours.
Methodology validated in MBA research on ML adoption in life sciences.
University of Winchester, 2023 • n=213 professionals
Limited early access spots available. Corporate email required.
Request Early Access ↑